NSE: ANURAS | BSE: 543275

Expensive Rocket

Download real time

1316.20 -5.10 (-0.39%)

Near 52W High of ₹1374.80

390.7K NSE+BSE Volume

NSE 16 Jan, 2026 3:31 PM (IST)

14,984.7

Market Cap

High in industry

Beta 1Year

Very Low volatility

Anupam Rasayan India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ANURAS, BSE:543275 Anupam Rasayan India Ltd.

Search Inside the pdf :

Anupam Rasayan India Ltd.

21 Aug 2025

1316.20

-0.39%

Strong Q1FY26 momentum; robust order book underpins healthy growth outlook

Accumulate: Anupam Rasayan India Ltd.

Deven Choksey

We believe the outlook remains positive, with strong growth visibility across agrochemicals, pharma, and polymers, while personal care should deliver steady performance.

Promoters unpledged 1.52% of shares in last quarter. Total pledge stands at 15.99% of promoter holdings

Anupam Rasayan India Ltd.

04 Oct 2023

1316.20

-0.39%

ANUPAM RASAYAN INDIA

Not Rated: Anupam Rasayan India Ltd.

Prabhudas Lilladhar

Promoters unpledged 1.52% of shares in last quarter. Total pledge stands at 15.99% of promoter holdings

Anupam Rasayan India Ltd.

12 Mar 2021

1316.20

-0.39%

IPO Note - Exciting Chemistry - Subscribe

IPO Note: Anupam Rasayan India Ltd.

Prabhudas Lilladhar

Manufacturing (CSM) company, operates in Life sciences (95% of rev) and other specialty chemicals (5%) verticals. It is favorably placed in the sweet spot to capture the rising demand for specialty chemicals given its strong relationships with MNCs (Key clients- Syngenta, Sumitomo and UPL), leadership competencies into multi-step synthesis & complex chemistries such as etherification, hydrogenation, alkylation, nitration, etc and superior...

Promoters unpledged 1.52% of shares in last quarter. Total pledge stands at 15.99% of promoter holdings

Anupam Rasayan India Ltd.

12 Mar 2021

1316.20

-0.39%

Anupam Rasayan

IPO Subscribe: Anupam Rasayan India Ltd.

Angel Broking

Anupam Rasayan India Ltd. is a company engaged in the custom synthesis and manufacturing of specialty chemicals in India. Company started its business as a partnership firm in 1984 as a manufacturer of conventional products and have, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty

Anupam Rasayan India.. has an average target of 1230.00 from 1 broker.

Anupam Rasayan India Ltd.

10 Mar 2021

1316.20

-0.39%

Anupam Rasayan India Limited IPO Note 10032021

IPO Note: Anupam Rasayan India Ltd.

HDFC Securities

Anupam Rasayan India Limited IPO Note Issue Open: Mar 12 Mar 16, 2021 Price Band: Rs. 553 555 (discount of Rs.55 for eligible employees) *Issue Size: 13,693,694 eq shares (including Employee Reservation of 220,000 Eq sh) *Issue Size: Rs. 757.3 760.0 cr Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail atleast 35% eq sh

Promoters unpledged 1.52% of shares in last quarter. Total pledge stands at 15.99% of promoter holdings

Anupam Rasayan India Ltd.

10 Mar 2021

1316.20

-0.39%

Anupam Rasayan India - IPO

IPO Note: Anupam Rasayan India Ltd.

ICICI Securities Limited

To expand business by capitalising on industry opportunities, organic, inorganic growth network In 2019, the Indian market for custom synthesis and manufacturing was valued at US$11.5 billion in 2019 for specialty chemicals accounting for ~6% of the global custom synthesis and manufacturing market. Custom synthesis manufacturing is on the rise in India while the contract research and manufacturing services market is expected to grow at 12% in the next five years, owing to strong growth from end-use demand. In addition, the China...

Anupam Rasayan India.. has an average target of 1230.00 from 1 broker.

Anupam Rasayan India Ltd.

10 Mar 2021

1316.20

-0.39%

Anupam Rasayan India Ltd. IPO Note

IPO Note: Anupam Rasayan India Ltd.

Ashika Research

Anupam Rasayan India Ltd. (ARIL) is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: F&S; Report). The company evolved into custom synthesis and manufacturing of life science related specialty chemicals and...

Anupam Rasayan India.. has an average target of 1230.00 from 1 broker.

VOTE: Is Anupam Rasayan India Ltd. worth buying?

78 Votes:

Buy 78.21%

Sell 16.67%

Hold 5.13%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Not Rated SEE REPORTS >

pdf